By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

CK Life Sciences Int'l., (Holdings) Inc. (0775.HK)

HKSE Currency in HKD
$0.92
-$0.01
-1.08%
Last Update: 1 Sept 2025, 05:07
$8.84B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.34 - $1.10
52 Week Range

0775.HK Stock Price Chart

Explore CK Life Sciences Int'l., (Holdings) Inc. interactive price chart. Choose custom timeframes to analyze 0775.HK price movements and trends.

0775.HK Company Profile

Discover essential business fundamentals and corporate details for CK Life Sciences Int'l., (Holdings) Inc. (0775.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

16 Jul 2002

Employees

2.03K

CEO

Lee Yuen

Description

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. CK Life Sciences Int'l., (Holdings) Inc. was founded in 1999 and is headquartered in Tai Po, Hong Kong.

0775.HK Financial Timeline

Browse a chronological timeline of CK Life Sciences Int'l., (Holdings) Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 18 Mar 2025

EPS came in at -$0.01 , while revenue for the quarter reached $2.89B .

Earnings released on 13 Aug 2024

EPS came in at $0.00 , while revenue for the quarter reached $2.64B .

Earnings released on 19 Mar 2024

EPS came in at -$0.00 , while revenue for the quarter reached $2.74B .

Earnings released on 1 Aug 2023

EPS came in at $0.00 , while revenue for the quarter reached $2.58B .

Dividend declared on 23 May 2023

A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 5 Jun 2023.

Earnings released on 14 Mar 2023

EPS came in at $0.01 , while revenue for the quarter reached $2.74B .

Earnings released on 30 Jun 2022

EPS came in at $0.01 , while revenue for the quarter reached $2.54B .

Dividend declared on 20 May 2022

A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 1 Jun 2022.

Earnings released on 31 Dec 2021

EPS came in at $0.01 , while revenue for the quarter reached $2.76B .

Earnings released on 30 Jun 2021

EPS came in at $0.01 , while revenue for the quarter reached $2.64B .

Dividend declared on 18 May 2021

A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 31 May 2021.

Earnings released on 16 Mar 2021

EPS came in at $0.00 , while revenue for the quarter reached $2.56B .

0775.HK Stock Performance

Access detailed 0775.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run